1-4 of 4
neurotoxicity syndromes
Close
Sort by
Journal Articles

CAR T-cell therapy: is it prime time in myeloma?

Surbhi Sidana, Nina Shah
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 260–265.
https://doi.org/10.1182/hematology.2019000370
Published: 2019
Journal Articles

No free rides: management of toxicities of novel immunotherapies in ALL, including financial

Tania Jain, Mark R. Litzow
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 25–34.
https://doi.org/10.1182/asheducation-2018.1.25
Published: 2018
Journal Articles

Therapy of primary CNS lymphoma: role of intensity, radiation, and novel agents

Andrés José María Ferreri
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 565–577.
https://doi.org/10.1182/asheducation-2017.1.565
Published: 2017
Journal Articles

An Update on Therapy of Primary Central Nervous System Lymphoma

Lisa M. DeAngelis, Fabio M. Iwamoto
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2006) 2006 (1): 311–316.
https://doi.org/10.1182/asheducation-2006.1.311
Published: 2006